Daiichi Sankyo Still Paying Fines for Benicar Doctor Kickbacks

Pharmaceutical giant Daiichi Sankyo has been ordered to pay another fine, the time in New Jersey, totaling $690,000. This comes after reaching a settlement in January to pay the U.S. federal government and Medicaid programs $39 million. This latest fine was an expansion of the previous settlement where a whistleblower accused the company of soliciting doctors to file false insurance claims for their drugs Azor, Benicar, Tribenzor and Welchol, all of which are derivative medications based on Benicar.

Recently a multidistrict litigation (MDL) suit against Daiichi Sankyo was transferred to a judge in New Jersey as well. The MDL addresses the suffering and pain suffered by victims who took the prescription drug Benicar and its derivatives. The drug is currently being linked to sprue-like enteropathy and villous atrophy, two potentially fatal and long lasting intestinal conditions. Symptoms include: dehydration, chronic diarrhea, nausea, vomiting, and significant weight loss.

Does My Doctor Know About the Potential Dangers of Daiichi Sankyo Drugs?

If you have taken Azor, Benicar, Benicar HCT, or Tribenzor and have experienced these symptoms, contact Colson Hicks Eidson. Complex pharmaceutical cases like this require experienced representation. We have handled similar MDL cases, and we would like to get you the help you need. Consult our personal injury lawyers and let us review your case for free.

Colson Hicks EidsonInjury Attorneys



Tags:

Leave a Reply

Your email address will not be published. Required fields are marked *